摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3-(3-chloro-4-methoxyphenyl)-1H-pyrazol-4-yl)pyridine | 1309605-97-7

中文名称
——
中文别名
——
英文名称
4-(3-(3-chloro-4-methoxyphenyl)-1H-pyrazol-4-yl)pyridine
英文别名
4-[5-(3-chloro-4-methoxyphenyl)-1H-pyrazol-4-yl]pyridine
4-(3-(3-chloro-4-methoxyphenyl)-1H-pyrazol-4-yl)pyridine化学式
CAS
1309605-97-7
化学式
C15H12ClN3O
mdl
——
分子量
285.733
InChiKey
JSNYDUXWLYWBIL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    50.8
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase
    作者:Saif Ullah、Mohammed I. El-Gamal、Sumera Zaib、Hanan S. Anbar、Seyed-Omar Zaraei、Rawan M. Sbenati、Julie Pelletier、Jean Sévigny、Chang-Hyun Oh、Jamshed Iqbal
    DOI:10.1016/j.bioorg.2020.103783
    日期:2020.6
    on human nucleotide pyrophosphatase/phosphodiesterase 1 and -3 (ENPP1 and ENPP3) isoenzymes. Compounds 1c-e were the most potent inhibitors of ENPP1 with sub-micromolar IC50 values (0.69, 0.18, and 0.40 µM, respectively. Moreover, compound 1b was the most potent inhibitor of ENPP3 (IC50 = 0.21 µM). They were much more potent than the reference standard inhibitor, suramin (IC50 values against ENPP1
    合成了具有吡啶-吡唑-苯硫脲吡啶-吡唑-苯磺酰胺支架的一系列六个化合物(1a-f)。筛选目标化合物以评估其对人核苷酸焦磷酸酶/磷酸二酯酶1和-3(ENPP1和ENPP3)同工酶的抑制作用。化合物1c-e是最有效的ENPP1抑制剂,亚微摩尔IC50值分别为0.69、0.18和0.40 µM;此外,化合物1b是最有效的ENPP3抑制剂(IC50 = 0.21 µM)。比参考标准抑制剂强力的苏拉明(针对ENPP1和-3的IC50值分别为7.77和0.89 µM)此外,还研究了这6种化合物对癌细胞系(HeLa,MCF-7和1321N1)的细胞毒性作用和正常细胞系(BHK-21)。化合物1e对所有三种癌细胞系均具有活性,但是对MCF-7表现出优先的细胞毒性(IC50 = 16.05 µM),与顺铂的药效相当。所有测试的化合物对正常细胞均显示出低或可忽略的细胞毒性作用。与顺铂相比,它们对癌细胞的选择
  • Discovery of a potent p38α/MAPK14 kinase inhibitor: Synthesis, in vitro/in vivo biological evaluation, and docking studies
    作者:Mohammed I. El-Gamal、Hanan S. Anbar、Hamadeh Tarazi、Chang-Hyun Oh
    DOI:10.1016/j.ejmech.2019.111684
    日期:2019.12
    article reports the synthesis of new triarylpyrazole derivatives possessing urea or amide linker, and their biological activities at molecular, cellular, and in vivo levels. Compound 2b was the most potent inhibitor of p38α/MAPK14 kinase (IC50 = 22 nM) among this series. Molecular docking studies were conducted to understand the kinase inhibitory variations and the basis of selectivity. Compound 2b was able
    本文报道了具有尿素或酰胺连接基的新的三芳基吡唑生物的合成及其在分子,细胞和体内平的生物活性。在该系列中,化合物2b是p38α/ MAPK14激酶最有效的抑制剂(IC50 = 22 nM)。进行了分子对接研究以了解激酶抑制变异和选择性的基础。在nanoBRET细胞激酶试验中,化合物2b能够抑制HEK293细胞内的p38α/ MAPK14激酶,EC50值为0.55μM,与达沙替尼的效价相当。化合物2b抑制脂多糖诱导的THP-1细胞中TNF-α的产生,IC50值为58 nM。另外,化合物2b显示出针对hERG的低效力。它对hERG的效力比E-4031低622.38倍,因此该化合物具有心脏毒性的风险非常小。化合物2b在人和大鼠血浆中在体外也显示出高血浆稳定性。化合物2b的体内PK曲线是可以接受的,并且其抗炎作用与双氯芬酸相当,对胃没有致溃疡的副作用。
  • Antiproliferative Diarylpyrazole Derivatives as Dual Inhibitors of the ERK Pathway and COX-2
    作者:Mohammed I. El-Gamal、Hong Seok Choi、Kyung Ho Yoo、Daejin Baek、Chang-Hyun Oh
    DOI:10.1111/cbdd.12186
    日期:2013.9
    A series of 3,4‐diarylpyrazole‐1‐carboxamide derivatives was designed and synthesized. A selected group of the target compounds was tested for in vitro antiproliferative activities over a panel of 60 cancer cell lines at the National Cancer Institute (NCI, Bethesda, MD, USA) at a single‐dose concentration of 10 μm, and the four most active compounds 9a, 9l, 9n, and 10o were further tested in a five‐dose testing mode to determine their IC50 values over the 60 cell lines. In addition, a selected group of target compounds were tested for inhibitory effect over cyclooxygenase isozymes. Compounds 9a, 9l, 9n, and 10o were also tested for MEK and ERK kinase inhibitory activity using Western blot assay. Compound 10o was selective toward melanoma cell line subpanel, and its antiproliferative activity may be attributed to selective cyclooxygenase‐2 inhibition and ERK pathway inhibition.
查看更多